Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

AGM Statement

12 May 2020 12:00

RNS Number : 6434M
Macfarlane Group PLC
12 May 2020
Β 

Β 

12 May 2020

Β 

At the Annual General Meeting ("AGM") held in Glasgow today, Stuart Paterson, Chairman of Macfarlane Group PLC ("Macfarlane" or the "Company") made the following statement.

Trading

As previously reported in our COVID-19 update on 30 March 2020, the first quarter of 2020 delivered a strong trading performance with Group sales growth of 2% and profitability well ahead of the same period in 2019. The acquisitions made in 2019 both performed to expectations in this period.

As a result of Government actions to address the COVID-19 crisis, we expect demand levels in the second quarter to reduce to between 75% and 80% of those seen in the second quarter of 2019. We are managing our cost base in line with the reduced levels of activity and we would expect the second quarter to be a profitable period of trading albeit well below that achieved in the first quarter.

Customers

Following the introduction of "lockdown" by the Government, our customers in the hygiene, household essentials, medical and food sectors continue to demonstrate strong demand. These customers play a vital role in helping to meet the challenges of COVID-19 and we continue to support them. All our sites remain operational, we are fully engaged with customers and offering an increasingly flexible service in response to their fast-changing needs. Some sectors we serve, such as automotive, aerospace and certain retail segments, have been materially impacted by the lockdown and their business has reduced significantly as a result.

People

The Board is committed to following the Government's guidance for COVID-19. Our intention during this challenging period is to ensure that we protect the health and wellbeing of our people. We have implemented home working programmes, workplace distancing and enhanced hygiene protocols. In line with the UK Government's aim to preserve employment we have furloughed approximately 30% of staff through the Coronavirus Job Retention Scheme.

The Board wishes to express its gratitude to all Macfarlane staff for their commitment, support and flexibility in these challenging times.

Liquidity

The Company has a strong balance sheet and liquidity headroom. Net bank debt, which at 31 December 2019 was Β£12.7 million, has now reduced below Β£6.0 million, albeit with the benefit of taxation deferrals, board salary reductions and bonus deferrals which in total amount to Β£4.0m. Following the actions taken, there remains significant headroom on the Group's principal bank facility of up to Β£30.0 million with Lloyds Banking Group, which is available until June 2022. The Company is in compliance with the covenants for the facility.

As a key measure to conserve cash, the Board took the decision not to propose the 2019 final dividend at today's AGM, which will reduce cash outflows by Β£2.8 million in the second quarter of 2020. The Company has been a regular dividend payer for a number of years and the Board remains committed to providing dividend income to shareholders. Once trading has recovered in line with more normal levels and we have more clarity about the longer-term outlook, the Board's intention is to recommence dividend payments either by augmenting regular dividends or by declaring a special dividend.

Β 

Summary

Given the current uncertainty and concerns around the pace of the potential recovery, it is not possible for the Company to provide meaningful guidance on trading for the financial year ending 31 December 2020. However, based on actions taken to date and current levels of trading, we expect the business to remain profitable in 2020 and to operate within the current borrowing facility. Further announcements will be made on the anticipated 2020 performance when the Board has more clarity.

Β 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Β 

Stuart Paterson Chairman

Β 

Β 

Peter Atkinson Chief Executive

Β 

Β 

John Love Finance Director

Β 

Β 

Β 

Β 

Β 

Spreng Thomson

Tel: 0141 548 5191

Β 

Callum Spreng

Mob: 07803 970103

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

Β 

Notes to Editors:

Β· Macfarlane Group PLC is listed on the London Stock Exchange (LSE: MACF) in the Industrials Sector

Β· The company is headquartered in Glasgow, Scotland and has more than 70 years' experience in the UK packaging industry. Macfarlane Group's businesses are:

o Macfarlane Packaging is the leading UK distributor of a comprehensive range of protective packaging products

o Labels designs and prints high quality self-adhesive and resealable labels, principally for FMCG companies

o Packaging Design and Manufacture designs and produces protective packaging for high value, fragile products

Β· Macfarlane Group employs over 925 people at 31 sites, principally in the UK, but also in Ireland and Sweden.

Β· The company has 15,000+ customers in the UK, Europe and the USA providing 600,000+ lines to a wide range of industry sectors including: consumer goods; food manufacturing; logistics; internet retail; mail order; electronics; defence and aerospace.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
AGMSFAFSEESSEFI
Date   Source Headline
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSLaunch of up to £4 million share buyback programme
13th May 20253:29 pmRNSResults of Annual General Meeting
13th May 20257:00 amRNSAGM Trading Update
17th Apr 20252:27 pmRNSNotice of AGM
28th Mar 20259:29 amRNSDirector/PDMR Shareholding
3rd Mar 20258:34 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAnnual Results 2024
12th Feb 20257:00 amRNSNotice of Results
13th Jan 20257:00 amRNSAcquisition of The Pitreavie Group Limited
28th Nov 20247:00 amRNSTrading Update
6th Sep 202411:58 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSHalf-year Report
1st Aug 20247:00 amRNSNotice of Results & Investor Presentation
16th Jul 20247:00 amRNSAppointment of Non-Executive Director
8th Jul 20247:00 amRNSAquisition of Polyformes
7th May 20244:24 pmRNSResults of Annual General Meeting
7th May 20247:00 amRNSAGM trading update
25th Apr 202410:36 amRNSNotice of Annual General Meeting
11th Apr 20244:56 pmRNSHolding(s) in Company
8th Apr 20241:59 pmRNSHolding(s) in Company
3rd Apr 202411:15 amRNSHolding(s) in Company
28th Mar 20242:22 pmRNSDirector/PDMR Shareholding
28th Mar 202411:15 amRNSDirector / PDMR Shareholding & EBT share purchase
19th Mar 20247:00 amRNSIssue of Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSAcquisition of Allpack Packaging Supplies Limited
29th Feb 20247:00 amRNSAnnual Results 2023
26th Feb 20241:46 pmRNSInvestor Presentation via Investor Meet Company
14th Feb 202410:29 amRNSNotice of Results
13th Dec 202310:00 amRNSBoard Changes
23rd Nov 20237:00 amRNSTrading Update
31st Oct 20238:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.